1
|
Caimi P, Eder J, Jacobsen E, Jacobson C, LaCasce A, Shipp M, Chapuy B, Labriola-Tomphins E, Boisserie F, Passe S, Chesné E, Pierceall W, Zhi J, DeMario M, Vaishampayan U, Dowlati A, Shapiro G, Fisher D, Armand P. A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/REFRACTORY (R/R) MYC-EXPRESSING DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). Hematol Oncol 2017. [DOI: 10.1002/hon.2438_134] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- P.F. Caimi
- Medicine - Hematology and Oncology; University Hospitals Seidman Cancer Center; Cleveland USA
| | - J.P. Eder
- Medicine / Section of Medical Oncology; Yale University Medical Center; New Haven USA
| | - E.D. Jacobsen
- Division of Hematologic Neoplasia; Dana Farber Cancer Institute; Boston USA
| | - C.A. Jacobson
- Division of Hematologic Neoplasia; Dana Farber Cancer Institute; Boston USA
| | - A.S. LaCasce
- Division of Hematologic Neoplasia; Dana Farber Cancer Institute; Boston USA
| | - M.A. Shipp
- Division of Hematologic Neoplasia; Dana Farber Cancer Institute; Boston USA
| | - B. Chapuy
- Division of Hematologic Neoplasia; Dana Farber Cancer Institute; Boston USA
| | - E. Labriola-Tomphins
- Roche Innovation Center New York; Roche Pharma Research and Early Development; New York USA
| | - F. Boisserie
- Roche Innovation Center New York; Roche Pharma Research and Early Development; New York USA
| | - S. Passe
- Roche Innovation Center New York; Roche Pharma Research and Early Development; New York USA
| | - E. Chesné
- Roche Innovation Center Basel; Roche Pharma Research and Early Development; Basel Switzerland
| | - W. Pierceall
- Roche Innovation Center New York; Roche Pharma Research and Early Development; New York USA
| | - J. Zhi
- Roche Innovation Center New York; Roche Pharma Research and Early Development; New York USA
| | - M. DeMario
- Roche Innovation Center New York; Roche Pharma Research and Early Development; New York USA
| | | | - A. Dowlati
- Medicine - Hematology and Oncology; University Hospitals Seidman Cancer Center; Cleveland USA
| | - G.I. Shapiro
- Division of Hematologic Neoplasia; Dana Farber Cancer Institute; Boston USA
| | - D.C. Fisher
- Division of Hematologic Neoplasia; Dana Farber Cancer Institute; Boston USA
| | - P. Armand
- Division of Hematologic Neoplasia; Dana Farber Cancer Institute; Boston USA
| |
Collapse
|